Sign up USA
Proactive Investors - Run By Investors For Investors

Dova Pharmaceuticals to raise US$70mln as it prices IPO

Dova will sell IPO shares to investors, priced between US$15 and US$17.
US dollar bills
It could raise between US$69mln to US$79mln

Specialist drug develop Dova Pharmaceuticals told investors it expects to raise US$69.1mln, as it priced its upcoming stock market float.

Dova, in a filing to the Securities and Exchange Commission (SEC), revealed plans to sell just over 4mln new IPO shares between US$15 and US$17 per share.

If all options and overallotments are taken up, Dova will raise up to US$79.4mln of proceeds.

It is anticipated that the pharmaceutical shares will list on the Nasdaq, under the symbol ‘DOVA’.

Jamie_55a91591db06b.jpg


Register here to be notified of future INDU Company articles
View full INDU profile View Profile

US Market News Timeline

Related Articles

picture of drug lab
February 07 2017
Amryt Pharma’s strategy to acquire, in-license and then develop drugs for hard to treat, so-called orphan diseases has been seeing some good progress.
GW_Pharma.png
June 07 2017
Midatech has three lead R&D programmes: a carcinoid syndrome treatment; a liver cancer drug; and a brain cancer therapy
Copyright © Proactiveinvestors.com, 2017. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use